Omixon and Algimed Sign Partnership Agreement

14/01/2019

At Omixon we are working hard to expand our customer base and it is always a pleasure and excitement to share the news of new collaborations, partnerships and distribution agreements. This time we are happy to announce that with the help of the Minsk-based Algimed, Omixon is now represented...

Happy Holidays from Omixon!

21/12/2018

From all of us at Omixon, we wish you a very happy Holiday season – without you, this year would not have been this eventful, successful and exciting. Happy Ho-Ho-Holotyping! Looking forward to working with you in 2019! Omixon Team Omixon Holiday Song – Rudolf the Red-coat Lab...

The Year in Blogposts – Our Favourite News and Announcements in 2018

18/12/2018

Another year has passed by… and what a year we have had! In 2018, we reached more milestones: opened our new lab in Budapest, released Holotype HLA v3.0, collaborated with PIRCHE on epitope determination, and received ISO and CE certificates. We hired new and promoted “old” colleagues, and...

Omixon and AGBL Partner for Extensive Middle East and North-Africa Distribution Deal

29/11/2018

Omixon and Alliance Global FZ-LLC are pleased to announce the execution of an exclusive distribution agreement to cover markets in the Middle East, Africa and Central Asia. The partnership builds on Omixon’s existing customer base in some of the covered markets including Saudi Arabia and Kuwait. AGBL will further...

Stories of Hope – Interesting Transplants Around the World

27/11/2018

Written by Renata Santos (Field Application Scientist, Omixon) A story of the Roman Catholic history reported the third-century saints Damian and Cosmas replaced a gangrenous leg of the Roma deacon, Justinian, with the leg of a deceased Ethiopia man (1). The evolution of transplant can be traced from ancient...